ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Extracellular Vesicles Derived from Huc-MSCs Alleviate Rat Hepatic Ischemia-Reperfusion Injury by Suppressing Oxidative Stress and Neutrophil Inflammatory Response

    J. Yao,1,2 J. Cai,1,2 J. Zheng,1,2 L. Chen,1,2 Y. Zhang,1,2 Y. Yang.1,2

    1Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Guangzhou, Guangdong, China; 2Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, .

    Mesenchymal stem cells (MSCs) have been reported possessing therapeutic effects on immunoregulation, tissue repair and regeneration from bench to bedside. Extracellular vesicles (EVs) derived from…
  • 2018 American Transplant Congress

    An Open-Label Proof-of-Principle Phase 2a Study to Evaluate Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance (ASCOTT)

    A. Chruscinski,1 H. Atkins,2 M. Macarthur,1 C. Anne Marie,2 D. Grant,1 C. Bredsen,2 E. Renner,1 L. Lilly,1 N. Selzner,1 O. Adeyi,1 R. Smith,1 S. Moshkelgosha,1 A. Humar,1 S. Juvet,1 G. Levy.1

    1Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada; 2Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, Canada.

    Background: Long-term survival of recipients of solid organ transplants is hampered by chronic rejection, disease recurrence and immunosuppression-induced toxicity. Self-tolerance is re-established after autologous hematopoietic…
  • 2018 American Transplant Congress

    The AKI-Predict-Score: A New Prediction Model for Acute Kidney Injury after Liver Transplantation

    M. Kalisvaart,1 A. Schlegel,1 I. Umbro,2 K. Roberts,1 D. Mirza,1 T. Perera,1 J. Isaac,1 A. P. Mitterhofer,2 J. de Jonge,3 P. Muiesan.1

    1Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom; 2Internal Medicine, Sapienza University, Rome, Italy; 3Surgery, Erasmus MC University Medical Center, Rotterdam, Netherlands.

    BackgroundPostoperative acute kidney injury (AKI) is a frequent complication after liver transplantation and associated with impaired survival rates, chronic kidney disease and higher costs. Although…
  • 2018 American Transplant Congress

    Hypothermic Machine Perfusion Protects Rabbit Kidney Graft through Down Regulation SPP1-MMP7 Signaling Axis

    Q. Hu,1 Z. Zhong,1 S. Xue,1 W. Liang,1 J. Lan,1 J. Liang,1 Y. Xiong,1 Y. Wang,1 Q. Ye.1,2

    1Zhongnan Hospital of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan, China; 2The 3rd Xiangya Hospital of Central Sourth University, Changsha, China.

    Background: Multicenter studies have indicated that hypothermic machine perfusion(HMP) can be used to prolong cold ischemia time with high-quality preservation and allow utilization of kidney…
  • 2018 American Transplant Congress

    Designing Novel Selective Immunoproteasome Inhibitors Reveals a Critical Role of the Immunoproteasome in Protecting Antibody Secreting B Cells from Apoptosis

    J. Assaker,1 N. Murakami,1 S. Eskandari,1 M. Uehara,1 C. Nathan,2 H. Li,3 G. Lin,2 J. Azzi.1

    1Transplantation Renal Center, Harvard Medical School, Boston; 2Microbiology and Immunology, Weill Cornell Medicine, New York; 3Cryo-EM Structural Biology Laboratory, Van Andel Research Institute, Grand Rapids.

    Constitutive proteasomes (c-20S) are ubiquitously-expressed cellular proteases that degrade polyubiquitinated proteins and regulate cell functions. Its inhibitor, bortezomib, is a plasma cell-targeted therapy used in…
  • 2018 American Transplant Congress

    Improvement of Metabolic Function after Intra-Portal Allogeneic Islet Transplantation by Induction Treatment of the Non-Hematopoetic Erytropoetin Analogue Cibinetide in a Mouse Model

    M. Yao,1 M. Watanabe,1,2 S. Sun,1 B. Ericzon,1 T. Lundgren,1 M. Kumagai-Braesch.1

    1Department of Transplantation Surgery, Karolinska University Hospital, Stockholm, Sweden; 2Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

    IntroductionRecently, we have demonstrated that cibinetide, a non-hematopoetic erytropoetin analogue, protected pancreatic islets from cytokine-induced damage and apoptosis and ameliorated the early inflammatory response following…
  • 2018 American Transplant Congress

    The TRANSFORM Study: Infection Outcomes with Everolimus Plus Reduced Calcineurin Inhibitor and Mycophenolate Plus Standard Calcineurin Inhibitor Regimens in De Novo Kidney Transplant Recipients

    F. Vincenti, J. Cruzado, S. Mulgaonkar, V. Garcia, D. Kuypers, M. Buchler, F. Citterio, U. Huynh-Do, W-.L. Luo, P. Bernhardt, C. Sommerer.

    TRANSFORM Study Group, Novartis Pharma AG, Basel, Switzerland.

    Purpose: Post-transplant (Tx) bacterial and viral infections are known to affect graft and patient survival. Accumulating evidence supports the protective effect of everolimus (EVR) against…
  • 2018 American Transplant Congress

    Renal Function, Blood Pressure, and Histologic Changes in Living Kidney Transplant Recipients from Hypertensive Donors

    T. Dienemann, J. Schellenberg, K. Amann, K. Heller, A. Weidemann.

    Nephrology and Hypertension University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany.

    Little is known if a kidney from a hypertensive donor performs equally compared to a kidney from a non-hypertensive donor. The present study examines the…
  • 2018 American Transplant Congress

    Clinical Application of Mesenchymal Stromal Cells with a Simplified Protocol for ABO Incompatible Liver Transplantation in Severe Hepatic Failure Patients

    Y. Zhang,1,2 J. Zheng,1,2 J. Cai,1,2 J. Zhang,1,2 K. Zeng,1,2 J. Yao,1,2 Y. Yang.1,2

    1Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Guangzhou, Guangdong, China; 2Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, .

    Objective The purpose of this study was to test the safety and efficacy of mesenchymal stromal cells (MSCs) treatment with a simplified protocol for ABO…
  • 2018 American Transplant Congress

    Increased Pre-Transplant Rejection-Risk Measured with Allospecific T-Cells Predicts Delayed Immunosuppression Minimization in Children with Intestine Transplantation.

    K. Soltys, C. Ashokkumar, G. Mazariegos, G. Bond, M. Ningappa, A. Khanna, A. Ganoza, Q. Sun, R. Sindhi.

    Pediatric Abdominal Transplant, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA.

    BACKGROUND: Allospecific CD154+T-cytotoxic memory cells (CD154+TcM) are used clinically to predict acute cellular rejection (ACR) after intestine transplantation (ITx) in children <21 years old within…
  • « Previous Page
  • 1
  • …
  • 117
  • 118
  • 119
  • 120
  • 121
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences